BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 12040669)

  • 1. [Chemo-radiotherapy for malignant brain tumors].
    Kochi M; Ushio Y
    Gan To Kagaku Ryoho; 2002 May; 29(5):669-76. PubMed ID: 12040669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of treatment of 112 cases of primary CNS lymphoma.
    Yamanaka R; Morii K; Shinbo Y; Homma J; Sano M; Tsuchiya N; Yajima N; Tamura T; Hondoh H; Takahashi H; Kakuma T; Tanaka R
    Jpn J Clin Oncol; 2008 May; 38(5):373-80. PubMed ID: 18413337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
    Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
    Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
    Prados MD; Seiferheld W; Sandler HM; Buckner JC; Phillips T; Schultz C; Urtasun R; Davis R; Gutin P; Cascino TL; Greenberg HS; Curran WJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1147-52. PubMed ID: 15001257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma.
    Yang SH; Hong YK; Yoon SC; Kim BS; Lee YS; Lee TK; Lee KS; Jeun SS; Kim MC; Park CK
    Oncol Rep; 2007 Jun; 17(6):1359-64. PubMed ID: 17487391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.
    Levin VA; Hess KR; Choucair A; Flynn PJ; Jaeckle KA; Kyritsis AP; Yung WK; Prados MD; Bruner JM; Ictech S; Gleason MJ; Kim HW
    Clin Cancer Res; 2003 Mar; 9(3):981-90. PubMed ID: 12631596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas.
    Levin VA; Yung WK; Bruner J; Kyritsis A; Leeds N; Gleason MJ; Hess KR; Meyers CA; Ictech SA; Chang E; Maor MH
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):58-66. PubMed ID: 12007942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
    Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
    J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
    Geyer JR; Sposto R; Jennings M; Boyett JM; Axtell RA; Breiger D; Broxson E; Donahue B; Finlay JL; Goldwein JW; Heier LA; Johnson D; Mazewski C; Miller DC; Packer R; Puccetti D; Radcliffe J; Tao ML; Shiminski-Maher T;
    J Clin Oncol; 2005 Oct; 23(30):7621-31. PubMed ID: 16234523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors.
    Duffner PK; Horowitz ME; Krischer JP; Friedman HS; Burger PC; Cohen ME; Sanford RA; Mulhern RK; James HE; Freeman CR
    N Engl J Med; 1993 Jun; 328(24):1725-31. PubMed ID: 8388548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy. A Phase II study.
    Brandes AA; Tosoni A; Vastola F; Pasetto LM; Coria B; Danieli D; Iuzzolino P; Gardiman M; Talacchi A; Ermani M
    Cancer; 2004 Nov; 101(9):2079-85. PubMed ID: 15372474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas.
    Levin VA; Prados MR; Wara WM; Davis RL; Gutin PH; Phillips TL; Lamborn K; Wilson CB
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):75-83. PubMed ID: 7721642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors.
    Choi LM; Rood B; Kamani N; La Fond D; Packer RJ; Santi MR; Macdonald TJ
    Pediatr Blood Cancer; 2008 May; 50(5):970-5. PubMed ID: 17941070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preradiation chemotherapy of children and young adults with malignant brain tumors: results of the German pilot trial HIT'88/'89.
    Kühl J; Müller HL; Berthold F; Kortmann RD; Deinlein F; Maass E; Graf N; Gnekow A; Scheurlen W; Göbel U; Wolff JE; Bamberg M; Kaatsch P; Kleihues P; Rating D; Sörensen N; Wiestler OD
    Klin Padiatr; 1998; 210(4):227-33. PubMed ID: 9743957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does chemotherapy benefit the patient with a central nervous system glioma?
    Rodriguez LA; Levin VA
    Oncology (Williston Park); 1987 Nov; 1(9):29-36, 40-1. PubMed ID: 3079493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
    Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
    J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperfractionated radiotherapy and multi-agent chemotherapy (procarbazine, ACNU and vincristine) for high-grade gliomas: a prospective study.
    Ogawa K; Yoshii Y; Toita T; Saito A; Kakinohana Y; Iraha S; Sugimoto K; Tsuchida Y; Tamaki W; Adachi G; Hyodo A; Murayama S
    Anticancer Res; 2006; 26(3B):2457-62. PubMed ID: 16821632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial.
    Taphoorn MJ; van den Bent MJ; Mauer ME; Coens C; Delattre JY; Brandes AA; Sillevis Smitt PA; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; Allgeier A; Bottomley A;
    J Clin Oncol; 2007 Dec; 25(36):5723-30. PubMed ID: 18089866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.